Q4-2010 presentation from Biotec Pharmacon
(Thomson Reuters ONE) -
Biotec Pharmacon presents today, February 17th, its interim report for
the fourth quarter and the full year 2010.
Speakers:
CEO Svein W. F. Lien, and managing director of ArcticZymes AS; Jan Buch
Andersen.
Please find the presentation attached together with complete interim report.
The presentation is also available as webcast with log-on at www.biotec.no.
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Interim report Q4-10 complete:
http://hugin.info/136141/R/1489893/425472.pdf
Presentation Q4-2010:
http://hugin.info/136141/R/1489893/425470.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biotec Pharmacon ASA via Thomson Reuters ONE
[HUG#1489893]
Unternehmensinformation / Kurzprofil:
Datum: 17.02.2011 - 08:01 Uhr
Sprache: Deutsch
News-ID 51612
Anzahl Zeichen: 1333
contact information:
Town:
Tromsø
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 202 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Q4-2010 presentation from Biotec Pharmacon"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotec Pharmacon ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
